ナノビブロニックスは 業績の改善とP/Eの低下にもかかわらず 重要な指標で同業者を追い抜いており 変動が高く成長見通しは弱くなっています Nanovibronix trails peers in key metrics despite better earnings and lower P/E, with higher volatility and weaker growth outlook.

低強度表面音波技術を用いた CEマーク付きキャセター製品を開発している医療機器会社である Nanovibronix (FEED) は,収益が高く,価格比率が低いにもかかわらず,13の主要指標のうち8で同業者の後ろにいます. Nanovibronix (FEED), a medical device company developing CE-marked catheter products using low-intensity surface acoustic wave technology, trails its industry peers on eight of 13 key metrics despite stronger earnings and a lower price-to-earnings ratio. 会社の組織的および内部所有権は低い.ベータが2.21の株価変動率が高い. 利益率と成長予測は外科および歯科機器部門の競合他社に比べて弱かった. The company has lower institutional and insider ownership, higher stock volatility with a beta of 2.21, and weaker profitability and growth expectations compared to competitors in the surgical and dental instruments sector.